Hasil Pencarian  ::  Simpan CSV :: Kembali

Hasil Pencarian

Ditemukan 11 dokumen yang sesuai dengan query
cover
Shintia Christina
"[ABSTRAK
Latar belakang : Kanker payudara lanjut lokal (KPLL) adalah kanker payudara stadium III.Modalitas terapi KPLL adalah pembedahan, kemoterapi, radioterapi, hormonal terapi dan terapi target. Respon kemoterapi neoadjuvan terdiri dari respon klinis dan respon patologi. Penilaian respon kemoterapi neoadjuvan penting untuk memprediksi angka ketahanan hidup dan dapat menjadi pedoman kemoterapi selanjutnya. Penilaian respon patologi selama ini bersifat kuantitatif dan sering tidak selaras dengan respon klinis. Perubahan jumlah selularitas dapat terlihat, tetapi kualitas sel tumor tersebut tidak dapat diketahui dengan pulasan Haematoxylin-eosin (HE) pada fase awal fragmentasi DNA, sehingga penilaian respon patologi perlu dilakukan secara kuantitatif dan kualitatif yaitu menilai selularitas sel tumor dan persentase apoptosis.
Bahan dan cara : Dilakukan penelitian retrospektif analitik secara potong lintang pada kanker payudara lanjut lokal tahun 2010-2014 di Departemen Patologi Anatomi FKUI/RSCM dan divisi bedah onkologi RSCM. Sampel biopsi dan reseksi dibandingkan untuk mengevaluasi penurunan selularitas, kemudian diklasifikasikan ke derajat Miller- Payne (MP). Sampel reseksi dipulas dengan TUNEL dan dihitung persentase apoptosis. Penurunan selularitas antara biopsi dan mastektomi dengan TUNEL merupakan Modifikasi MP. Hasil : Perubahan respon patologi dengan Modifikasi MP menimbulkan peningkatan derajat pada 24 kasus. Tidak terdapat hubungan antara respon klinis dengan persentase apoptotis (p=0,108), respon klinis dengan MP (p=1,000) dan Modifikasi MP (p=0,655). Tidak didapatkan hubungan dan adanya korelasi yang lemah antara penyusutan massa tumor secara klinis dengan jumlah sel tumor yang mati dengan MP (p=0,177; r =0,212) dan Modifikasi MP (p=0,609; r = 0,081). Terdapat perbedaan signifikan antara jumlah sel mati yang dinilai dengan MP dan Modifikasi MP (p =0,000).
Kesimpulan : Persentase apoptosis tidak berhubungan dengan respon klinis. Modifikasi MP meningkatkan nilai derajat respon patologik, tetapi penilaian Modifikasi MP tetap tidak menunjukkan korelasi dengan respon klinik.ABSTRACT Background: Locally advanced breast cancer (LABC) is a stage III breast cancer. The management of LABC includes surgery, chemotherapy, radiotherapy, hormonal and targeted therapy. Responses to neoadjuvant (before surgery) chemotherapy consist of clinical and pathological responses. Evaluating chemotherapy response is essential to predict survival rate and it may become guidelines for the next chemotherapy in the future. Until now, the evaluation of pathological response only involves quantitative assessment and the clinical responses are often inconsistent with the pathological responses. Morphological changes of apoptotic cells can still be seen. However, the quality of the tumor cells is vague when the cells are stained with Hematoxylin-eosin (HE) during the first stage of DNA fragmentation. The evaluation of pathological responses; therefore, need to be performed by quantitative and qualitative methods, i.e. by evaluating the cellularity of tumor cells and the percentage of apoptosis.
Materials and method: A cross-sectional analytical retrospective study was conducted on the issue of locally advanced breast cancer between 2010 and 2014 at the Department of Anatomical Pathology, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital and Division of Surgical Oncology, Cipto Mangunkusumo Hospital. Specimens of biopsy and resection were compared to evaluate reduction in cellularity, which were subsequently categorized into stages of Miller-Payne (MP) classification. The specimens of resection were stained with TUNEL and the percentage of apoptosis was calculated. Reduction in cellularity between biopsy and mastectomy specimens with TUNEL staining is a modified MP methods.
Results: The evaluation of pathological responses using the modified MP method has increased the value of MP grading in 24 cases. We found no association between clinical responses with percentage of apoptosis (p=0,108), MP pathological responses (p=1,000) and modified MP (p=0,655). There is no association and weak correlation between decreasing tumor mass with MP (p=0,177; r=0,212) and modified MP (p=0,609; r=0,081). There was a correlation between the dead cell evaluated by MP and by modified MP. (p=0.000)
Conclusion: Apoptosis percentage does not correlate with clinical responses. Modified MP increases the degree or grading of pathological responses, but it does not improve the correlation with clinical responses., Background: Locally advanced breast cancer (LABC) is a stage III breast cancer. The management of LABC includes surgery, chemotherapy, radiotherapy, hormonal and targeted therapy. Responses to neoadjuvant (before surgery) chemotherapy consist of clinical and pathological responses. Evaluating chemotherapy response is essential to predict survival rate and it may become guidelines for the next chemotherapy in the future. Until now, the evaluation of pathological response only involves quantitative assessment and the clinical responses are often inconsistent with the pathological responses. Morphological changes of apoptotic cells can still be seen. However, the quality of the tumor cells is vague when the cells are stained with Hematoxylin-eosin (HE) during the first stage of DNA fragmentation. The evaluation of pathological responses; therefore, need to be performed by quantitative and qualitative methods, i.e. by evaluating the cellularity of tumor cells and the percentage of apoptosis.
Materials and method: A cross-sectional analytical retrospective study was conducted on the issue of locally advanced breast cancer between 2010 and 2014 at the Department of Anatomical Pathology, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital and Division of Surgical Oncology, Cipto Mangunkusumo Hospital. Specimens of biopsy and resection were compared to evaluate reduction in cellularity, which were subsequently categorized into stages of Miller-Payne (MP) classification. The specimens of resection were stained with TUNEL and the percentage of apoptosis was calculated. Reduction in cellularity between biopsy and mastectomy specimens with TUNEL staining is a modified MP methods.
Results: The evaluation of pathological responses using the modified MP method has increased the value of MP grading in 24 cases. We found no association between clinical responses with percentage of apoptosis (p=0,108), MP pathological responses (p=1,000) and modified MP (p=0,655). There is no association and weak correlation between decreasing tumor mass with MP (p=0,177; r=0,212) and modified MP (p=0,609; r=0,081). There was a correlation between the dead cell evaluated by MP and by modified MP. (p=0.000)
Conclusion: Apoptosis percentage does not correlate with clinical responses. Modified MP increases the degree or grading of pathological responses, but it does not improve the correlation with clinical responses.]"
Fakultas Kedokteran Universitas Indonesia, 2015
SP-PDF
UI - Tugas Akhir  Universitas Indonesia Library
cover
Ukhti Jamil Rustiasari
"[ABSTRAK
Latar Belakang : Esofagus Barrett (EB) merupakan lesi premaligna
adenokarsinoma esofagus yang meningkatkan risiko menjadi adenokarsinoma
sebesar 30-125 kali. EB didefinisikan sebagai perubahan epitel esofagus normal
digantikan oleh epitel kolumnar metaplastik, meskipun secara universal belum ada
kesepakatan definisi. Kehadiran sel goblet (metaplasia intestinal) sebagai penanda
EB hingga saat ini masih kontroversi. CDX2 adalah gen regulator transkripsi dalam
diferensiasi intestinal dan diketahui terekspresi pada EB. Studi mengenai ekspresi
protein Cdx2 menggunakan pulasan imunohistokimia pada EB dengan metaplasia
kolumnar (MK) maupun metaplasia intestinal (MI) masih terbatas. Penelitian ini
bertujuan untuk mengetahui ekspresi Cdx2 pada EB dengan MK dan MI serta
hubungannya dengan derajat keparahan endoskopi.
Bahan dan cara : Dilakukan pulasan imunohistokimia Cdx2 pada 38 kasus dari 19
pasien EB dengan MK dan 19 dengan MI. Penilaian dilakukan dengan menghitung
skor pulasan yang menilai intensitas pulasan dan persentase area positif.
Imunoekspresi Cdx2 dinilai positif apabila skor pulasan ≥ 0,1.
Hasil : Ekspresi Cdx2 ditemukan pada 12 (63,16%) kasus MK dan pada 16
(84,21%) kasus MI. Didapatkan nilai median kelompok MK sebesar 0,15 dan MI
sebesar 0,58. Terdapat perbedaan bermakna antara skor Cdx2 pada kelompok MK
dan MI (p=0,05). Diperoleh korelasi bermakna antara kehadiran MI dan skor Cdx2
dengan nilai korelasi positif lemah (0,322). Tidak terdapat hubungan bermakna
antara derajat keparahan endoskopi dengan jenis metaplasia (p=0,794), derajat
inflamasi berdasarkan histopatologik (p=0,300) maupun dengan positivitas Cdx2
(p=0,278).
Kesimpulan : Hasil penelitian menunjukkan ekspresi Cdx2 dapat digunakan sebagai penanda kehadiran MI pada kasus EB dengan MK tanpa gambaran sel goblet.ABSTRACT Background : Barrett?s Esophagus (BE) is premalignan lesion of the esophageal
adenocarcinoma that increases risk of adenocarcinoma as much as 30-125 times.
BE is defined as normal esophageal epithelium that is changed by columnar
epithelial metaplasia. Nevertheless, there is no general agreement about its
definition yet. Currently, the presence of goblet cell (intestinal metaplasia) as an
indicator of BE is still controversial. Cdx2 is a regulator transcript gene in intestinal
differentiation and is known expressed in BE. Study about Cdx2 protein expression
using immunohistochemistry staining in BE with columnar metaplasia (CM) or
intestinal metaplasia (IM) is still limited. This research is intended to find Cdx2
expression in BE with CM and IM as well as its relationship with the severity degree
of endoscopy.
Material and Method : Immunohistochemistry staining of Cdx2 was performed
on 38 cases (i.e. each 19 BE patients with CM and IM). The assessment was
evaluated by calculating staining score that assessed staining intensity and
percentage of positive area. Immunoexpression was considered as positive if
staining score ≥ 0.1.
Result : Cdx2 expression was found on 12 CM patients (63,16%) and 16 IM
patients (84,21%). Median scores of 0,15 and 0,58 were obtained from CM and IM
groups, respectively. There was a significant difference between Cdx2 score of CM
group and IM group (p = 0,05). Significant correlation between the presence of IM
and Cdx2 score was weak positive (0,322). There was no relationship between
severity degree of endoscopy with types of metaplasia (p=0,794), histopathologic
inflammation degree (p=0,300) or Cdx2 positivity (p=0,278).
Conclusion : This study shows that Cdx2 expression can be used an indicator of IM presence on EB cases with CM without goblet cell appearance.;Background : Barrett?s Esophagus (BE) is premalignan lesion of the esophageal
adenocarcinoma that increases risk of adenocarcinoma as much as 30-125 times.
BE is defined as normal esophageal epithelium that is changed by columnar
epithelial metaplasia. Nevertheless, there is no general agreement about its
definition yet. Currently, the presence of goblet cell (intestinal metaplasia) as an
indicator of BE is still controversial. Cdx2 is a regulator transcript gene in intestinal
differentiation and is known expressed in BE. Study about Cdx2 protein expression
using immunohistochemistry staining in BE with columnar metaplasia (CM) or
intestinal metaplasia (IM) is still limited. This research is intended to find Cdx2
expression in BE with CM and IM as well as its relationship with the severity degree
of endoscopy.
Material and Method : Immunohistochemistry staining of Cdx2 was performed
on 38 cases (i.e. each 19 BE patients with CM and IM). The assessment was
evaluated by calculating staining score that assessed staining intensity and
percentage of positive area. Immunoexpression was considered as positive if
staining score ≥ 0.1.
Result : Cdx2 expression was found on 12 CM patients (63,16%) and 16 IM
patients (84,21%). Median scores of 0,15 and 0,58 were obtained from CM and IM
groups, respectively. There was a significant difference between Cdx2 score of CM
group and IM group (p = 0,05). Significant correlation between the presence of IM
and Cdx2 score was weak positive (0,322). There was no relationship between
severity degree of endoscopy with types of metaplasia (p=0,794), histopathologic
inflammation degree (p=0,300) or Cdx2 positivity (p=0,278).
Conclusion : This study shows that Cdx2 expression can be used an indicator of IM presence on EB cases with CM without goblet cell appearance., Background : Barrett’s Esophagus (BE) is premalignan lesion of the esophageal
adenocarcinoma that increases risk of adenocarcinoma as much as 30-125 times.
BE is defined as normal esophageal epithelium that is changed by columnar
epithelial metaplasia. Nevertheless, there is no general agreement about its
definition yet. Currently, the presence of goblet cell (intestinal metaplasia) as an
indicator of BE is still controversial. Cdx2 is a regulator transcript gene in intestinal
differentiation and is known expressed in BE. Study about Cdx2 protein expression
using immunohistochemistry staining in BE with columnar metaplasia (CM) or
intestinal metaplasia (IM) is still limited. This research is intended to find Cdx2
expression in BE with CM and IM as well as its relationship with the severity degree
of endoscopy.
Material and Method : Immunohistochemistry staining of Cdx2 was performed
on 38 cases (i.e. each 19 BE patients with CM and IM). The assessment was
evaluated by calculating staining score that assessed staining intensity and
percentage of positive area. Immunoexpression was considered as positive if
staining score ≥ 0.1.
Result : Cdx2 expression was found on 12 CM patients (63,16%) and 16 IM
patients (84,21%). Median scores of 0,15 and 0,58 were obtained from CM and IM
groups, respectively. There was a significant difference between Cdx2 score of CM
group and IM group (p = 0,05). Significant correlation between the presence of IM
and Cdx2 score was weak positive (0,322). There was no relationship between
severity degree of endoscopy with types of metaplasia (p=0,794), histopathologic
inflammation degree (p=0,300) or Cdx2 positivity (p=0,278).
Conclusion : This study shows that Cdx2 expression can be used an indicator of IM presence on EB cases with CM without goblet cell appearance.]"
Fakultas Kedokteran Universitas Indonesia, 2015
SP-PDF
UI - Tugas Akhir  Universitas Indonesia Library
cover
Niniek Hardini
"[ABSTRAK
Latar belakang: Malignant peripheral nerve sheath tumor (MPNST) adalah sarkoma jaringan lunak yang sulit dibedakan dengan beberapa sarkoma sel spindel karena morfologinya yang serupa. MPNST bersifat agresif dengan angka rekurensi yang tinggi dan cenderung bermetastasis terutama ke paru. Salah satu tahap metastasis adalah invasi dengan cara mendegradasi matriks ekstraseluler dimana Matrix Metalloproteinase (MMP) memainkan peranan penting dalam proses ini. MMP tipe gelatinase yaitu MMP-2 dan MMP-9 memiliki kemampuan dalam mendegradasi membran basal dan kolagen fibrilar sehingga dapat membuka jalur invasi bagi sel tumor. MMP-2 mampu mendegradasi lebih banyak tipe kolagen dan MES non kolagen dibandingkan MMP-9. Penelitian ini bertujuan untuk menilai hubungan antara peningkatan ekspresi MMP-2 dengan derajat keganasan histologik dan variabel prognostik klinis lainnya.
Bahan dan cara: Dilakukan pulasan imunohistokimia MMP-2 pada 39 kasus yang terdiri atas 19 MPNST derajat rendah dan 20 MPNST derajat tinggi. Selanjutnya dilakukan analisis hubungan antara peningkatan ekspresi MMP-2 dengan derajat keganasan dan variabel klinis seperti usia, jenis kelamin, ukuran dan lokasi tumor.
Hasil: Peningkatan ekspresi MMP-2 ditemukan pada 19 (95%) kasus MPNST derajat tinggi dan 3 kasus (15,8%) kasus MPNST derajat rendah (p=0.000). Terdapat hubungan yang kuat antara peningkatan ekspresi MMP-2 dengan derajat keganasan MPNST. Tidak ditemukan hubungan antara ekspresi MMP-2 dengan jeni usia, jenis kelamin, ukuran dan lokasi tumor.
Kesimpulan: Peningkatan ekspresi MMP-2 sejalan dengan peningkatan derajat histologik, sehingga dapat digunakan untuk membantu menentukan progresifitas MPNST.

ABSTRACT
Background: Malignant peripheral nerve sheath tumor (MPNST) is a sarcoma that is difficult to differentiate with other spindle cell sarcomas, because of their similar morphology. The behavior of MPNST is aggressive, with a high recurrence and tend to metastases hematogenous, especially to lung. Important step of metastases is invasion by degradating extracellular matrix, in which Matrix Metalloproteinase (MMP) play important role in this process. Gelatinase type of MMP, MMP-2 and MMP-9 have ability to degrade basal membrane and fibriler collagen, in order to open the way of invasion. MMP-2 can degrade type collagen and non collagen extracellular matrix than MMP-9. The aim of this study is to see the correlation between expression of MMP-2 and histopathology grading and other prognostic clinical variables.
Methods: This study enrolled 39 cases of consisted of 19 low grade MPNST and 20 high grade MPNST. The case were stained for MMP-2 imunnohistochemistry and the expression of MMP-2 were scored. Analysis the correlation between over expression of MMP-2 and histopathology grading and other clinical variables , such as age, sex, size and location of the tumor.
Results: Overexpression of MMP-2 was observed in 19 (95%) cases of high grade MPNST and 3 (15,8%) cases of low grade MPNST (p=0.000). There is a significant correlation between MMP-2 over expression and histopathology grade. There is no correlation between MMP-2 expression and age, sex, siize and location of tumor.
Conclusion: High expression of MMP-2 is in parallel with high histologic grade, therefore it may be of additional use as prognostic factor., ackground: Malignant peripheral nerve sheath tumor (MPNST) is a sarcoma that is difficult to differentiate with other spindle cell sarcomas, because of their similar morphology. The behavior of MPNST is aggressive, with a high recurrence and tend to metastases hematogenous, especially to lung. Important step of metastases is invasion by degradating extracellular matrix, in which Matrix Metalloproteinase (MMP) play important role in this process. Gelatinase type of MMP, MMP-2 and MMP-9 have ability to degrade basal membrane and fibriler collagen, in order to open the way of invasion. MMP-2 can degrade type collagen and non collagen extracellular matrix than MMP-9. The aim of this study is to see the correlation between expression of MMP-2 and histopathology grading and other prognostic clinical variables
Methods: This study enrolled 39 cases of consisted of 19 low grade MPNST and 20 high grade MPNST. The case were stained for MMP-2 imunnohistochemistry and the expression of MMP-2 were scored. Analysis the correlation between over expression of MMP-2 and histopathology grading and other clinical variables , such as age, sex, size and location of the tumor.
Results:. Overexpression of MMP-2 was observed in 19 (95%) cases of high grade MPNST and 3 (15,8%) cases of low grade MPNST (p=0.000). There is a significant correlation between MMP-2 over expression and histopathology grade. There is no correlation between MMP-2 expression and age, sex, siize and location of tumor.
Conclusion: High expression of MMP-2 is in parallel with high histologic grade, therefore it may be of additional use as prognostic factor.]"
Fakultas Kedokteran Universitas Indonesia, 2015
SP-PDF
UI - Tugas Akhir  Universitas Indonesia Library
cover
Paramita Pandansari
"[ABSTRAK
Latar Belakang: Penggunaan biomaterial berupa bahan tandur tulang dan membran untuk prosedur Guided Bone Regeneration (GBR) sangat diperlukan di bidang bedah maksilofasial dan, untuk mengatasi defek tulang yang dapat terjadi oleh berbagai sebab. Penelitian ini bertujuan untuk mengetahui efek pemakaian bahan tandur tulang DFDBX dengan membran perikardium (MPK) bovine pada defek tulang kalvaria tikus.
Bahan dan Metode: Studi eksperimental ini menggunakan 45 ekor tikus Sprague Dawley sebagai hewan coba dibagi dalam 3 kelompok secara acak. Ciritical size defect sebesar diameter 5 mm dibuat pada tulang kalvaria seluruh hewan coba. Kelompok I merupakan kelompok kontrol, tidak diberikan perlakuan dan defek dibiarkan sembuh dengan sendirinya, kelompok II yang diberi DFDBX, dan pada kelompok III defek diisi dengan DFDBX dan ditutup dengan MPK (DFDBX+MPK). Setelah 1,4 dan 8 minggu dilakukan dilakukan pengorbanan pada kelompok hewan coba, dilanjutkan dengan evaluasi secara radiologik, histopatologik untuk reaksi radang, pertumbuhan tulang dan pemeriksaan imunohistokimia dengan osteokalsin. Data dianalisis secara statistik dengan menggunakan uji ANOVA.
Hasil: Penilaian radiografik diperoleh perbedaan bermakna pada rerata densitas area defek minggu ke 8 antara kelompok kontrol dengan DFDBX+MPK (p<0,001) dan antara kelompok DFDBX dengan DFDBX+MPK (p=0,03).
Pertumbuhan tulang baru pada minggu ke 8 tertinggi adalah pada kelompok DFDBX+MPK dengan perbedaan bermakna dengan kelompok kontrol (p=0,016) dan dengan kelompok DFDBX nilai p=0,048. Ekspresi osteokalsin minggu ke-8 menunjukkan perbedaan bermakna antara kelompok kontrol dengan kelompok DFDBX (p<0,001) maupun dengan kelompok DFDBX+MPK (p=0,0013), namun tidak terdapat perbedaan bermakna antara kelompok DFDBX dengan kelompok MPK (p=1,000).
Kesimpulan: Penggunaan DFDBX dengan kombinasi MPK terbukti secara radiologik, histopatologik dan imunohistokimia dapat meningkatkan regenerasi tulang pada defek tulang kalvaria.

ABSTRACT
Background: Reconstruction of cranial and maxillofacial defects is a challenging task. The standard method has included bone grafting and using membrane in guided bone regeneration procedure. Using biomaterial such as bone grafting and membrane for Guided Bone Regeneration (GBR) procedures is an essential issue in maxillofacial and dental reconstruction surgery to overcome bone defects caused by various etiologies. Our study was aimed to identify the effect of using Demineralized Freeze-Dried Bone Xenograft (DFDBX) with (or without) bovine pericardium membrane (PCM) on the treatment of rats calvarial bone defects.
Materials and Method: The experimental study used 45 Sprague-Dawley rats as the experimental animals, which were categorized randomly into three groups, i.e. the control group, DFDBX group, and DFDBX+PCM group. The 5-mm-critical-sized calvarial defects were created in all experimental animals. The first group was a control group, which did not receive any treatment with self-limiting defects; while subjects in the second group received DFDBX (DFDBX group) and in the third group, the defects were filled with DFDBX and PCM (DFDBX + PCM group). Animals were sacrified at the 1st, 4th, and 8th weeks following the surgery. Subsequently, an evaluation was carried out using radiological analysis, histopathological assay to observe inflammatory reaction and bone growth, as well as immunohistochemical analysis of osteocalcin. Data were analyzed statistically using ANOVA test. The specimens were embedded ini paraffin, serially cut, and stained with hematoxylin and eosin for analysis under light microscope. The inflammation reaction, new bone formation, and the rest of DFDBX and PCM were histomorphometrically evaluated. Immunohistochemical analysis of osteocalcin expression was performed.
Results: Radiological analysis demonstrated a significant difference of mean bone density in the defect area at the 8th week between subjects in the control group and those in DFDBX+PCM group (p < 0.001), as well as between subjects in the DFDBX group and those in DFDBX+PCM group (p = 0.03). The highest rate of bone healing at the 8th week was found in DFDBX+PCM group, which showed significant difference compared to the control group (p=0.016) and to DFDBX group (p=0.048). There was a significant difference of osteocalcin expression between the control group and DFDBX group (p < 0.001), as well as between the control group and DFDBX + PCM group (p=0,0013). However, there was no significant difference between the DFDBX group and the DFDBX+PCM group (p = 1.000).
Conclusion: Our radiological, histopahtological and immunohistochemical evaluation has demonstrated that DFDBX combined with PCM increases bone regeneration in the treatment of bone calvarial defect. ;Background :Reconstruction of cranial and maxillofacial defects is a challenging task.
The standard method has been bone grafting and using membrane in guided bone
regeneration procedure.
The aim of this study was to analyze the effect of Demineralized Freeze Dried Bone
Xenograft (DFDBX) with (or without)bovine pericardium membrane (PCM) on bone
regeneration, in surgically created critical-size defects in rat calvaria, radiographically,
histopathologically and immunohistochemically.
Material and Methods :Surgical critical-size bone defects were created in 45 animals
that randomly divided into three groups : control group, DFDBX group, and
DFDBX+PCM group. Animals were sacrified at 1, 4 and 8 weeks post surgery.
Radiological analysis was done. The specimens were embedded ini paraffin, serially cut,
and stained with hematoxylin and eosin for analysis under light microscope. The
inflammation reaction, new bone formation, and the rest of DFDBX and PCM were
histomorphometrically evaluated. Immunohistochemical analysis of osteocalcin
expression was performed.
Result : DFDBX and DFDBX+PCM groups demonstrated superior bone healing
compared with control group. Group DFDBX+PCM showmore advanced healing at 8
weeks post surgery and show the highest density radiographically as compared with the
other group DFDBX and control.Immunohistochemistry revealed the presence of
osteocalcin in osteoblast and matrix extracellular and show significant differences were
noted between DFDBX and DFDBX+PCM to control groups.
Conclusion : Application of DFDBX combined with bovine PCM gave the best result in bone regeneration of critical size defects in rat calvaria. , Background :Reconstruction of cranial and maxillofacial defects is a challenging task.
The standard method has been bone grafting and using membrane in guided bone
regeneration procedure.
The aim of this study was to analyze the effect of Demineralized Freeze Dried Bone
Xenograft (DFDBX) with (or without)bovine pericardium membrane (PCM) on bone
regeneration, in surgically created critical-size defects in rat calvaria, radiographically,
histopathologically and immunohistochemically.
Material and Methods :Surgical critical-size bone defects were created in 45 animals
that randomly divided into three groups : control group, DFDBX group, and
DFDBX+PCM group. Animals were sacrified at 1, 4 and 8 weeks post surgery.
Radiological analysis was done. The specimens were embedded ini paraffin, serially cut,
and stained with hematoxylin and eosin for analysis under light microscope. The
inflammation reaction, new bone formation, and the rest of DFDBX and PCM were
histomorphometrically evaluated. Immunohistochemical analysis of osteocalcin
expression was performed.
Result : DFDBX and DFDBX+PCM groups demonstrated superior bone healing
compared with control group. Group DFDBX+PCM showmore advanced healing at 8
weeks post surgery and show the highest density radiographically as compared with the
other group DFDBX and control.Immunohistochemistry revealed the presence of
osteocalcin in osteoblast and matrix extracellular and show significant differences were
noted between DFDBX and DFDBX+PCM to control groups.
Conclusion : Application of DFDBX combined with bovine PCM gave the best result in bone regeneration of critical size defects in rat calvaria. ]"
Fakultas Kedokteran Universitas Indonesia, 2015
SP-PDF
UI - Tugas Akhir  Universitas Indonesia Library
cover
Isabelle Deli
"[ABSTRAK
Latar belakang: Neoplasma sel plasma (NSP) adalah proliferasi sel plasma neoplastik yang tumbuh soliter menjadi plasmasitoma tulang soliter (PTS) dan plasmasitoma ekstrameduler (PEM) serta multipel (MM)). Saat ini perjalanan penyakit dari plasmasitoma menjadi MM sulit diprediksi. Bartl mengklasifikasikan derajat keganasan berdasarkan histomorfologik menjadi rendah, sedang dan tinggi. Penelitian ini bertujuan menggunakan klasifikasi Bartl untuk menilai perjalanan PTS dan PEM menjadi MM dihubungkan dengan ekspresi TP53 dan Ki-67.
Bahan dan cara: Pada 32 kasus NSP yang berasal dari PTS 14 kasus, PEM 5 kasus, maupun MM sebanyak 13 kasus, diklasifikasikan menjadi 3 kelompok derajat keganasan menurut Bartl yaitu derajat keganasan ringan, sedang dan tinggi. Selanjutnya dilakukan pulasan IHK TP53 dan Ki-67 pada seluruh kasus dan dihitung persentase positifitas.
Hasil: Berdasarkan derajat keganasan, derajat rendah ditemukan pada 10 (31,2%) MM, derajat sedang pada 5 (15,6%) PTS dan derajat tinggi pada 2 (6,2%) PTS dan PEM. Peningkatan ekspresi TP53 ditemukan pada derajat Bartl yaitu median derajat rendah 4%, derajat sedang 16%, dan derajat tinggi 10%. Terdapat perbedaan ekspresi TP53 yang bermakna antara derajat keganasan rendah dan sedang (p=0,004). Rerata indeks proliferasi Ki-67 pada derajat keganasan rendah 57%, derajat sedang 44,6%, dan derajat tinggi 32,6%. Tidak ditemukan perbedaan antara indeks proliferasi Ki-67 dengan derajat keganasan menurut Bartl (p=0,339). Tidak terdapat hubungan antara ekspresi TP53, Ki-67 dengan usia. Kesimpulan: Peningkatan ekspresi TP53 pada NSP sejalan dengan peningkatan derajat keganasan Bartl, terutama pada derajat rendah dan sedang. Klasifikasi Bartl ditambah dengan pulasan TP53 saja tidak cukup untuk memprediksi perkembangan PTS dan PEM menuju MM.

ABSTRACT
Background: Plasma cell neoplasm (PCN) is a neoplastic plasma cells proliferation including solitary bone plasmacytoma (SBP) and extramedullary plasmacytoma (EMP) and multiple myeloma (MM). Until now the development of disease to MM is unpredictable. Bartl classifies the degrees of malignancy histomorphologically as low, intermediate and high. This research aims using Bartl's classification and expression of TP53 and Ki-67 to assess the development of SBP and EMP to MM.
Materials and methods: In 32 cases of PCN derived from 14 cases of SBP, 5 cases of EMP, and 13 MM case, then classified into 3 groups based on Bartl's degrees of malignancy as low, intermediate, and high. Furthermore all cases stained by IHC TP53 and Ki-67 and evaluated the percentage of positivity. Results: Bartl's low degree was found in 10 (31,2%) MM case, intermediate in 5 (15,6%) SBP and high in 2 (6,2%) SBP and EMP. TP53 expression, obtainable at 4% of low, 16% of intermediate, and 10% of high degree. There is significant difference between TP53 expression in low and intermediate degree (p = 0,004). Mean proliferation index of Ki-67 is 57% in low, 44,6% in intermediate and 32,6% in high degree. There is no significant difference of Ki-67 proliferation indexes among the group (p = 0,339). There is no correlation between expressions TP53, Ki-67 and age.
Conclusion: Increasing expression TP53 is in line with Bartl's degrees of malignancy, especially on low and inter.;Background: Plasma cell neoplasm (PCN) is a neoplastic plasma cells proliferation including solitary bone plasmacytoma (SBP) and extramedullary plasmacytoma (EMP) and multiple myeloma (MM). Until now the development of disease to MM is unpredictable. Bartl classifies the degrees of malignancy histomorphologically as low, intermediate and high. This research aims using Bartl?s classification and expression of TP53 and Ki-67 to assess the development of SBP and EMP to MM.
Materials and methods: In 32 cases of PCN derived from 14 cases of SBP, 5 cases of EMP, and 13 MM case, then classified into 3 groups based on Bartl?s degrees of malignancy as low, intermediate, and high. Furthermore all cases stained by IHC TP53 and Ki-67 and evaluated the percentage of positivity. Results: Bartl?s low degree was found in 10 (31,2%) MM case, intermediate in 5 (15,6%) SBP and high in 2 (6,2%) SBP and EMP. TP53 expression, obtainable at 4% of low, 16% of intermediate, and 10% of high degree. There is significant difference between TP53 expression in low and intermediate degree (p = 0,004). Mean proliferation index of Ki-67 is 57% in low, 44,6% in intermediate and 32,6% in high degree. There is no significant difference of Ki-67 proliferation indexes among the group (p = 0,339). There is no correlation between expressions TP53, Ki-67 and age.
Conclusion: Increasing expression TP53 is in line with Bartl?s degrees of malignancy, especially on low and inter, Background: Plasma cell neoplasm (PCN) is a neoplastic plasma cells proliferation including solitary bone plasmacytoma (SBP) and extramedullary plasmacytoma (EMP) and multiple myeloma (MM). Until now the development of disease to MM is unpredictable. Bartl classifies the degrees of malignancy histomorphologically as low, intermediate and high. This research aims using Bartl’s classification and expression of TP53 and Ki-67 to assess the development of SBP and EMP to MM.
Materials and methods: In 32 cases of PCN derived from 14 cases of SBP, 5 cases of EMP, and 13 MM case, then classified into 3 groups based on Bartl’s degrees of malignancy as low, intermediate, and high. Furthermore all cases stained by IHC TP53 and Ki-67 and evaluated the percentage of positivity. Results: Bartl’s low degree was found in 10 (31,2%) MM case, intermediate in 5 (15,6%) SBP and high in 2 (6,2%) SBP and EMP. TP53 expression, obtainable at 4% of low, 16% of intermediate, and 10% of high degree. There is significant difference between TP53 expression in low and intermediate degree (p = 0,004). Mean proliferation index of Ki-67 is 57% in low, 44,6% in intermediate and 32,6% in high degree. There is no significant difference of Ki-67 proliferation indexes among the group (p = 0,339). There is no correlation between expressions TP53, Ki-67 and age.
Conclusion: Increasing expression TP53 is in line with Bartl’s degrees of malignancy, especially on low and inter]"
Fakultas Kedokteran Universitas Indonesia, 2015
SP-PDF
UI - Tugas Akhir  Universitas Indonesia Library
cover
Yayi Dwina Bilianti Susanto
"Latar belakang: Interpretasi cairan peritoneum yang tepat secara sitopatologi sangat mempengaruhi tatalaksana dan prognosis pasien, padahal pemeriksaan sitopatologi cairan peritoneum masih memiliki nilai negatif palsu dan positif palsu yang cukup tinggi, dan hingga saat ini penelitian tentang arsitektur sitopatologi maupun penanda sitomorfologi yang mengarahkan pada adanya sel neoplasma di cairan peritoneum masih menunjukkan hasil yang beragam.
Bahan dan cara kerja: Penelitian potong lintang dengan data sekunder berupa slaid dan formulir sediaan sitopatologi cairan peritoneum yang memiliki data berpasangan dengan diagnosis histopatologi. Diagnosis klinis berupa neoplasma epitelial ovarium. Slaid dan formulir diambil dari arsip Departemen Patologi Anatomik FKUI/RSCM tahun 2011 - 2012, dilakukan pembacaan ulang semua slaid sitopatologi dengan diagnosis akhir dikategorikan sebagai positif atau negatif, peneliti membaca pula sediaan histopatologi untuk mengetahui morfologi sel pada lesi, kemudiaan dilakukan penilaian terhadap arsitektur sitopatologi berupa: selularitas, sel berkelompok, struktur papiler, intercelular windows, group contours, jisim psamoma, dan penanda sitomorfologi berupa: atipia inti, inti bertumpuk, anak inti, rasio inti:sitoplasma, ukuran inti, dan ukuran sel.
Hasil penelitian: Sampel penelitian sejumlah 47 sediaan sitopatologi dengan diagnosis sitopatologi akhir 34 kasus (72.3%) negatif, 13 kasus (27.7%) positif. Terdapat perbedaan bermakna arsitektur sitopatologi berupa: selularitas (p = 0.017), sel berkelompok (p = 0.001), intercellular windows (p = 0.00), group contours (p = 0.00), dan gambaran sitomorfologi berupa: atipia inti (p = 0.00), inti bertumpuk (p = 0.001), anak inti (p = 0.001), rasio inti:sitoplasma (p = 0.00), ukuran inti (p = 0.00), ukuran sel (p = 0.00) antara cairan peritoneum positif dan negatif. Melalui uji multivariat didapatkan penanda yang paling berpengaruh terhadap diagnosis sitopatologi positif atau negatif yaitu: intercellular windows, atipia inti, dan selularitas.
Kesimpulan: Terdapat tiga penanda yang paling berpengaruh terhadap diagnosis positif ditemukannya sel neoplasma ganas dalam cairan peritoneum pada kasus dengan lesi ovarium, secara berturut - turut yaitu: tidak ditemukannya intercellular windows pada kelompokan sel, sel memiliki atipia inti sedang hingga berat, dan selularitas lebih dari 20 kelompok dari keseluruhan sediaan apus.

Background : Peritoneal fluid cytopathology interpretation profoundly influences patients management and prognosis, however this practice still has high false positive and false negative value, and until now research concerning the architectural and cytomorphology features for detecting malignant cells in peritoneal fluid still has various result.
Materials and Methods : Cross sectional study using secondary data of peritoneal fluid cytopathology and histopathology slides and form, from patients with clinical diagnosis of ovarian epithelial neoplasm. The data was taken from the archive of Anatomical Pathology Department Cipto Mangunkusumo Hospital 2011 - 2012. The researchers examined the cytopathology slides and also examined the histopatology slide for morphology comparison, and then make a final cytopathological diagnosis of positive peritoneal fluid containing neoplastic cells or negative. Architectural features including: cellularity, cells grouping, papillary structure, intercellular windows, group contours, psamoma bodies, and cytomorphology features including: nuclear atypia, overlapping nuclei, nucleoli, nuclei : cytoplasm ratio, the dimension of the nuclei and cells were also examined.
Result : There were 47 samples with final cytopathology diagnosis: 34 cases (72.3%) negative for neoplastic cells in the peritoneal fluid and 13 cases (27.7%) positive. There were significant differences in cytopathology architectural including cellularity (p = 0.017), cells grouping (p = 0.001), intercellular windows (p = 0.00), group contours (p = 0.00) and cytomorphology features including nuclear atypia (p = 0.00), overlapping nuclei (p = 0.001), nucleoli (p =0.001), nuclei : cytoplasm ratio (p = 0.00), the dimension of nuclei (p = 0.00), the dimension of cell (p = 0.00) between the positive and negative peritoneal fluid cytopathology. Using multivariate analysis there were 3 cytological features that have the strongest association with positive or negative peritoneal cytopathology diagnosis, they were: intercellular windows, nuclear atypia, and cellularity.
Conclusion: In peritoneal fluid cytopathology for examining ovarian lesion there were 3 cytological features that have the strongest association with finding neoplastic cells in peritoneal fluid, they were: the absent of intercellular windows, moderate to severe cytological atypia, and cellularity more than 20 groups in all smear preparation."
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2015
Ta-Pdf
UI - Tugas Akhir  Universitas Indonesia Library
cover
Weny Yusnita
"ABSTRAK
Latar belakang: Fibroadenoma dan tumor filodes jinak merupakan tumor
fibroepitelial dengan gambaran histopatologik yang tumpang tindih. Saat ini
banyak pengambilan jaringan tumor payudara secara core biopsy, termasuk pada
tumor fibroepitelial. Jumlah jaringan yang sedikit dan gambaran histopatologik
yang tumpang tindih sering menyulitkan Dokter Spesialis Patologi Anatomik
dalam menentukan diagnosis fibroadenoma dan tumor filodes jinak. Penelitian ini
bertujuan untuk mengetahui gambaran histopatologik apa saja yang bermakna
untuk mendiagnosis fibroadenoma dan tumor filodes jinak dan untuk menguji
apakah diagnosis fibroadenoma dan tumor filodes jinak pada core biopsy dengan
menggunakan sistem skoring lebih baik dibandingan tanpa skoring.
Bahan dan cara: Penelitian ini merupakan suatu uji diagnostik. 57 kasus
fibroadenoma dan tumor filodes jinak yang memiliki slaid core biopsy dan
mastektomi/lumpektomi/eksisi dinilai ulang tanpa sistem skoring dan
menggunakan skoring. Gambaran histopatologik yang dinilai pada sistem skoring
adalah selularitas stroma, atipia inti, fragmentasi jaringan, infiltrasi lemak, mitosis
dan heterogenitas stroma. Kemudian dilakukan analisis statistik, uji diagnostik
dan uji kappa.
Hasil: Selularitas stroma, heterogenitas stroma dan fragmentasi jaringan lebih
sering ditemukan pada tumor filodes jinak dan berbeda bermakna (p=0,001;
p=0,000; p=0,021). Spesifisitas pada sistem skoring meningkat sebesar 17,9%.
Nilai duga positif dan nilai duga negatif pada sistem skoring meningkat sebesar
11,9% dan 5,1%. Area under curve (AUC) meningkat 8,9%. Uji Cohen?s kappa
antara diagnosis core biopsy tanpa dan dengan skoring bernilai rendah (0,545).
Kesimpulan: Adanya peningkatan spesifisitas, nilai duga positif dan AUC
menunjukkan bahwa penilaian core biopsy sistem skoring lebih baik
dibandingkan tanpa skoring dan dapat menjadi acuan untuk diagnosis fibroadenoma dan tumor filodes jinak.
ABSTRACT
Background: Fibroadenoma and benign phyllodes tumor are kinds of fibroepithelial tumor which have overlapping histopathological features. Recently, core biopsy is commonly performed to determine breast tumor, including fibroepithelial tumor. Small amount of tissue and overlapped histopathological features often complicate the Pathologist in diagnosing both. This study aims to describe the histopathological appearance which needed to diagnose fibroadenoma and benign phyllodes tumor and to verify if the diagnosis of fibroadenoma and benign phyllodes tumor in core biopsy using scoring system is more accurate than without scoring system.
Method: This study was a diagnostic test, in which 57 cases of fibroadenoma and benign phyllodes tumor which had undergone core biopsy and mastectomy/excision were re-assessed using and without using scoring system. Histopathologic features which assessed using scoring system were stromal cellularity, nuclear atypia, tissue fragmentation, fat infiltration, mitotic figure, stromal heterogeneity. Analytical statistic, diagnostic test, accuracy test and Kappa test were done.
Results: Stromal cellularity, stromal heterogeneity and tissue fragmentation mostly found in benign phyllodes tumor and significantly different (p=0,001; p=0,000; p=0,021).There were significant differences between stromal cellularity (p=0,001), stromal heterogeneity (p=0,000), and tissue fragmentation (p=0,021) in diagnosis of benign phyllodes tumor. Specificity in scoring system increased by
17,9 %. Positive predictive value, negative predictive value and accuracy increased in scoring system (11,9% and 5,1%). Area under curve (AUC) increased by 8,9%. Cohen's Kappa test between core biopsy diagnosis without using and using scoring system had low result(0,545).
Conclusion: The increasing of specificity, positive predictive value, accuracy and AUC proved that core biopsy with scoring system is more accurate than without scoring. This can be used as reference to diagnose fibroadenoma and benign phyllodes tumor.;Background: Fibroadenoma and benign phyllodes tumor are kinds of fibroepithelial tumor which have overlapping histopathological features. Recently, core biopsy is commonly performed to determine breast tumor, including fibroepithelial tumor. Small amount of tissue and overlapped histopathological features often complicate the Pathologist in diagnosing both. This study aims to describe the histopathological appearance which needed to diagnose fibroadenoma and benign phyllodes tumor and to verify if the diagnosis of fibroadenoma and benign phyllodes tumor in core biopsy using scoring system is more accurate than without scoring system.
Method: This study was a diagnostic test, in which 57 cases of fibroadenoma and benign phyllodes tumor which had undergone core biopsy and mastectomy/excision were re-assessed using and without using scoring system. Histopathologic features which assessed using scoring system were stromal cellularity, nuclear atypia, tissue fragmentation, fat infiltration, mitotic figure, stromal heterogeneity. Analytical statistic, diagnostic test, accuracy test and Kappa test were done.
Results: Stromal cellularity, stromal heterogeneity and tissue fragmentation mostly found in benign phyllodes tumor and significantly different (p=0,001; p=0,000; p=0,021).There were significant differences between stromal cellularity (p=0,001), stromal heterogeneity (p=0,000), and tissue fragmentation (p=0,021) in diagnosis of benign phyllodes tumor. Specificity in scoring system increased by
17,9 %. Positive predictive value, negative predictive value and accuracy increased in scoring system (11,9% and 5,1%). Area under curve (AUC) increased by 8,9%. Cohen's Kappa test between core biopsy diagnosis without using and using scoring system had low result(0,545).
Conclusion: The increasing of specificity, positive predictive value, accuracy and AUC proved that core biopsy with scoring system is more accurate than without scoring. This can be used as reference to diagnose fibroadenoma and benign phyllodes tumor.;Background: Fibroadenoma and benign phyllodes tumor are kinds of fibroepithelial tumor which have overlapping histopathological features. Recently, core biopsy is commonly performed to determine breast tumor, including fibroepithelial tumor. Small amount of tissue and overlapped histopathological features often complicate the Pathologist in diagnosing both. This study aims to describe the histopathological appearance which needed to diagnose fibroadenoma and benign phyllodes tumor and to verify if the diagnosis of fibroadenoma and benign phyllodes tumor in core biopsy using scoring system is more accurate than without scoring system.
Method: This study was a diagnostic test, in which 57 cases of fibroadenoma and benign phyllodes tumor which had undergone core biopsy and mastectomy/excision were re-assessed using and without using scoring system. Histopathologic features which assessed using scoring system were stromal cellularity, nuclear atypia, tissue fragmentation, fat infiltration, mitotic figure, stromal heterogeneity. Analytical statistic, diagnostic test, accuracy test and Kappa test were done.
Results: Stromal cellularity, stromal heterogeneity and tissue fragmentation mostly found in benign phyllodes tumor and significantly different (p=0,001; p=0,000; p=0,021).There were significant differences between stromal cellularity (p=0,001), stromal heterogeneity (p=0,000), and tissue fragmentation (p=0,021) in diagnosis of benign phyllodes tumor. Specificity in scoring system increased by
17,9 %. Positive predictive value, negative predictive value and accuracy increased in scoring system (11,9% and 5,1%). Area under curve (AUC) increased by 8,9%. Cohen's Kappa test between core biopsy diagnosis without using and using scoring system had low result(0,545).
Conclusion: The increasing of specificity, positive predictive value, accuracy and AUC proved that core biopsy with scoring system is more accurate than without scoring. This can be used as reference to diagnose fibroadenoma and benign phyllodes tumor.;Background: Fibroadenoma and benign phyllodes tumor are kinds of fibroepithelial tumor which have overlapping histopathological features. Recently, core biopsy is commonly performed to determine breast tumor, including fibroepithelial tumor. Small amount of tissue and overlapped histopathological features often complicate the Pathologist in diagnosing both. This study aims to describe the histopathological appearance which needed to diagnose fibroadenoma and benign phyllodes tumor and to verify if the diagnosis of fibroadenoma and benign phyllodes tumor in core biopsy using scoring system is more accurate than without scoring system.
Method: This study was a diagnostic test, in which 57 cases of fibroadenoma and benign phyllodes tumor which had undergone core biopsy and mastectomy/excision were re-assessed using and without using scoring system. Histopathologic features which assessed using scoring system were stromal cellularity, nuclear atypia, tissue fragmentation, fat infiltration, mitotic figure, stromal heterogeneity. Analytical statistic, diagnostic test, accuracy test and Kappa test were done.
Results: Stromal cellularity, stromal heterogeneity and tissue fragmentation mostly found in benign phyllodes tumor and significantly different (p=0,001; p=0,000; p=0,021).There were significant differences between stromal cellularity (p=0,001), stromal heterogeneity (p=0,000), and tissue fragmentation (p=0,021) in diagnosis of benign phyllodes tumor. Specificity in scoring system increased by
17,9 %. Positive predictive value, negative predictive value and accuracy increased in scoring system (11,9% and 5,1%). Area under curve (AUC) increased by 8,9%. Cohen's Kappa test between core biopsy diagnosis without using and using scoring system had low result(0,545).
Conclusion: The increasing of specificity, positive predictive value, accuracy and AUC proved that core biopsy with scoring system is more accurate than without scoring. This can be used as reference to diagnose fibroadenoma and benign phyllodes tumor."
Fakultas Kedokteran Universitas Indonesia, 2015
SP-PDF
UI - Tugas Akhir  Universitas Indonesia Library
cover
Chandra Dewi Kartika Setyaningsih
"ABSTRAK
Latar Belakang :
Karsinoma kolorektal (KKR) merupakan penyebab kematian kedua di dunia dari seluruh jenis
kanker. KKR dapat disebabkan oleh defek dari MMR DNA. Microsatellite instability (MSI)
adalah penanda defek MMR DNA. KKR MSI-H memiliki gambaran karakteristik tertentu.
Tumor-infiltrating-lymphocyte (TIL) merupakan faktor prognosis. Hilangnya ekspresi PMS2 dan
MSH6 dapat sebagai penanda MSI. Penelitian ini bertujuan untuk menilai terjadinya MSI pada
KKR di sisi kiri dan sisi kanan kolon melalui Hilangnya ekspresi PMS2 dan MSH6, serta
mengetahui hubungan antara TIL dengan MSI-H.
Bahan dan Metode :
Dilakukan pulasan IHK PMS2 dan MSH6, serta penghitungan TIL. Penilaian dilakukan dengan
menghitung hilangnya ekspresi PMS2 dan MSH6 pada inti sel dan dikelompokkan ke dalam
kelompok mutasi dan tidak mutasi .Penghitungan TIL juga dikelompokkan ke dalam TIL tinggi
dan rendah, berdasarkan nilai titik potong
Hasil :
Didapatkan 27,8% kasus menunjukkan hilangnya ekspresi PMS2 dan MSH6 dengan 14,4%
kasus di distal kolon. TIL terbanyak di distal kolon 30% kasus. Tidak terdapat perbedaan
bermakna antara mutasi PMS2 dan MSH6 dengan lokasi (p=0,829) dan TIL (p=0,187). Terdapat
perbedaan bermakna antara usia dan lokasi (p=0,020) serta peningkatan ekspresi PMS2 dengan
MSH6 (p=0,06).
Kesimpulan :
MSI-H ditemukan pada 27,8% kasus. Penggunaan PMS2 dan MSH6 pada penelitian ini belum
dapat menggantikan 4 panel IHK. Terdapat kecenderungan dimana adenokarsinoma NOS
memiliki frekuensi mutasi lebih tinggi dari adenokarsinoma musinosum.
ABSTRACT
Background : Colorectal carcinoma (CRC) is the world second leading cause of death from all types of cancer.
CRC can be caused by a defect of MMR DNA. Microsatellite instability (MSI) is a marker of
DNA MMR defect. CRC MSI-H has a certain characteristic figures. Tumor-infiltrating
lymphocytes (TIL) isone of prognostic factor. Loss expression of the PMS2 and MSH6 can be
use as a marker of MSI. This study aims to assess the occurrence of MSI in CRC on the left side
and the right side of the colon through the loss of expression of PMS2 and MSH6, and
determine the relationship between TIL with MSI-H.
Materials and Methods :
Immunohistochemical staining using two marker, there is PMS2 and MSH6. We also counting
the number of TIL. Assessment by calculating the loss expression of PMS2 and MSH6 in the cell
nuclei and divided into two groups, the mutations and non mutations . TIL result also grouped
into high and low, based on the cutoff point.
Result :
There are 27.8% of cases showed loss of expression of PMS 2 and MSH6 with 14.4% of cases in
the distal colon. About 30% TIL cases located in distal colon. There were no significant
differences between PMS2 and MSH6 mutation with the location (p = 0.829) and TIL (p =
0.187). There are significant differences between age and location (p = 0.020) and increased
expression of PMS2 with MSH6 (p = 0.06). \
Conclusion :
MSI-H was found in 27.8% of cases. The use of PMS2 and MSH6 in this study have not been
able to replace 4 panels of IHC. There is a tendency where the adenocarcinoma NOS have a
higher mutation frequency than mucinous adenocarcinoma. ;Background :
Colorectal carcinoma (CRC) is the world second leading cause of death from all types of cancer.
CRC can be caused by a defect of MMR DNA. Microsatellite instability (MSI) is a marker of
DNA MMR defect. CRC MSI-H has a certain characteristic figures. Tumor-infiltrating
lymphocytes (TIL) isone of prognostic factor. Loss expression of the PMS2 and MSH6 can be
use as a marker of MSI. This study aims to assess the occurrence of MSI in CRC on the left side
and the right side of the colon through the loss of expression of PMS2 and MSH6, and
determine the relationship between TIL with MSI-H.
Materials and Methods :
Immunohistochemical staining using two marker, there is PMS2 and MSH6. We also counting
the number of TIL. Assessment by calculating the loss expression of PMS2 and MSH6 in the cell
nuclei and divided into two groups, the mutations and non mutations . TIL result also grouped
into high and low, based on the cutoff point.
Result :
There are 27.8% of cases showed loss of expression of PMS 2 and MSH6 with 14.4% of cases in
the distal colon. About 30% TIL cases located in distal colon. There were no significant
differences between PMS2 and MSH6 mutation with the location (p = 0.829) and TIL (p =
0.187). There are significant differences between age and location (p = 0.020) and increased
expression of PMS2 with MSH6 (p = 0.06). \
Conclusion :
MSI-H was found in 27.8% of cases. The use of PMS2 and MSH6 in this study have not been
able to replace 4 panels of IHC. There is a tendency where the adenocarcinoma NOS have a
higher mutation frequency than mucinous adenocarcinoma. ;Background :
Colorectal carcinoma (CRC) is the world second leading cause of death from all types of cancer.
CRC can be caused by a defect of MMR DNA. Microsatellite instability (MSI) is a marker of
DNA MMR defect. CRC MSI-H has a certain characteristic figures. Tumor-infiltrating
lymphocytes (TIL) isone of prognostic factor. Loss expression of the PMS2 and MSH6 can be
use as a marker of MSI. This study aims to assess the occurrence of MSI in CRC on the left side
and the right side of the colon through the loss of expression of PMS2 and MSH6, and
determine the relationship between TIL with MSI-H.
Materials and Methods :
Immunohistochemical staining using two marker, there is PMS2 and MSH6. We also counting
the number of TIL. Assessment by calculating the loss expression of PMS2 and MSH6 in the cell
nuclei and divided into two groups, the mutations and non mutations . TIL result also grouped
into high and low, based on the cutoff point.
Result :
There are 27.8% of cases showed loss of expression of PMS 2 and MSH6 with 14.4% of cases in
the distal colon. About 30% TIL cases located in distal colon. There were no significant
differences between PMS2 and MSH6 mutation with the location (p = 0.829) and TIL (p =
0.187). There are significant differences between age and location (p = 0.020) and increased
expression of PMS2 with MSH6 (p = 0.06). \
Conclusion :
MSI-H was found in 27.8% of cases. The use of PMS2 and MSH6 in this study have not been
able to replace 4 panels of IHC. There is a tendency where the adenocarcinoma NOS have a
higher mutation frequency than mucinous adenocarcinoma. "
Depok: Fakultas Kedokteran Universitas Indonesia, 2015
SP-PDF
UI - Tugas Akhir  Universitas Indonesia Library
cover
Retno Widyawati
"ABSTRAK
Latar belakang: Endometriosis merupakan kelainan ginekologik yang paling
sering ditemukan. Seperti halnya endometrium di uterus juga dapat terjadi
berbagai perubahan pada epitel yang melapisi kista endometriosis di ovarium,
antara lain metaplasia, hiperplasia, atipia bahkan perubahan ke arah keganasan.
Saat ini banyak penelitian yang menghubungkan antara endometriosis dan kanker
ovarium terutama jenis clear cell dan dikenal dengan istilah endometriosisassociated
ovarian carcinoma (EAOC) dan dilaporkan adanya mutasi yang
menginaktifkan gen supresor tumor (ARID1A), sehingga protein BAF250a tidak
diekpresikan pada Clear cell carcinoma (CCC) ovarii.
Bahan dan cara: Dilakukan pulasan imunohistokimia ARID1A pada sampel 20
kasus endometriosis non atipik, 20 kasus atipik dan 20 kasus CCC ovarii tahun
2012 hingga Maret 2015. Dari kelompok kasus CCC didapatkan 9 kasus EAOC.
Selanjutnya dilihat adakah perbedaan persentase ekspresi ARID1A pada
endometriosis non atipik, atipik, CCC ovarii serta endometriosis disertai CCC
(EAOC).
Hasil: Pada kelompok kasus endometriosis non atipik, atipik dan CCC ada
perbedaan bermakna persentase ekspresi ARID1A (uji Kruskal-Wallis p=0,0035).
Selanjutnya dilakukan analisis Post Hoc uji Mann-Whitney dan didapatkan
perbedaan bermakna persentase ekspresi ARID1A antara endometriosis non atipik
dan atipik dengan CCC ovarii (p=0,001 dan p=0,0015). Pada kelompok kasus
endometriosis non atipik, atipik dan endometriosis pada EAOC, didapatkan ada
perbedaan bermakna persentase ekspresi ARID1A (Uji Kruskal-Walis p=0,011).
Selanjutnya dilakukan analisis Post Hoc uji Mann-Whitney dan ada perbedaan
bermakna persentase ekspresi ARID1A antara endometriosis non atipik dan atipik
dengan EAOC (p=0,005 dan p=0,008).
Kesimpulan: Ekspresi ARID1A pada endometriosis non atipik dan atipik lebih
tinggi bermakna dibanding CCC ovarii dan EAOC. Sehingga ekspresi ARID1A
kemungkinan dapat digunakan sebagai petanda adanya transformasi ganas pada
endometriosis.
ABSTRACT
Background: Endometriosis is one of the most common gynecological
abnormalities found. Endometriosis cyst in the ovary also exhibited changes in
epithelial cyst just like endometrium in the uterus. Changes in the epithelial cells
also include metaplasia, hyperplasia, atyphia even changes toward malignan
characteristics. Nowadays, there are some research that linked endometriosis and
clear cell ovarian cancer which is known with endometriosis-associated ovarian
carcinoma (EAOC) it is reported that there?s a mutation that activated tumor
suppressor gene (ARID1A), so protein BAF250a is not expressed in Clear Cell
Carcinoma (CCC) in the ovarium.
Materials and Methods: Immunohistochemistry staining of ARID1A were done
in 20 samples of non-atypical endometriosis, 20 samples of atypical
endometriosis, 20 samples of CCC in the ovarium from the year 2012 until march
2015. From the group that experienced CCC we get 9 cases of EAOC. After that,
we see if there?s any difference in the percentage of ARID1A expression in nonatypical
endometrosis, atypical endometriosis, CCC in the ovarium and
endometriosis with CCC( EAOC).
Results: In non-atypical endometriosis, atypical and CCC cases groups there are
significant differences on the percentage of ARID1A expression (Kruskal-Walis
test p=0,0035). Post Hoc analysis were done using Mann-Whitney test and there
are significant differences on ARID1A expression between non-atypical and
atypical endometriosis with CCC (p=0,001 and p=0,0015). In non-atypical
endometriosis, atypical and EAOC groups there are significant differences on the
percentage of ARID1A expression (Kruskal-Walis test p=0,011). Post Hoc
analysis were done using Mann-Whitney test and there are significant differences
on ARID1A expression between non-atypical and atypical endometriosis with
EAOC (p=0,005 and p=0,008).
Conclusion: Expression of ARID1A in non atypical and atypical endometriosis
are significantly higher compared to ovarian CCC and EAOC. So, we can say that
ARID1A may be used as a marker for malignancy transformation in
endometriosis.
;Background: Endometriosis is one of the most common gynecological
abnormalities found. Endometriosis cyst in the ovary also exhibited changes in
epithelial cyst just like endometrium in the uterus. Changes in the epithelial cells
also include metaplasia, hyperplasia, atyphia even changes toward malignan
characteristics. Nowadays, there are some research that linked endometriosis and
clear cell ovarian cancer which is known with endometriosis-associated ovarian
carcinoma (EAOC) it is reported that there?s a mutation that activated tumor
suppressor gene (ARID1A), so protein BAF250a is not expressed in Clear Cell
Carcinoma (CCC) in the ovarium.
Materials and Methods: Immunohistochemistry staining of ARID1A were done
in 20 samples of non-atypical endometriosis, 20 samples of atypical
endometriosis, 20 samples of CCC in the ovarium from the year 2012 until march
2015. From the group that experienced CCC we get 9 cases of EAOC. After that,
we see if there?s any difference in the percentage of ARID1A expression in nonatypical
endometrosis, atypical endometriosis, CCC in the ovarium and
endometriosis with CCC( EAOC).
Results: In non-atypical endometriosis, atypical and CCC cases groups there are
significant differences on the percentage of ARID1A expression (Kruskal-Walis
test p=0,0035). Post Hoc analysis were done using Mann-Whitney test and there
are significant differences on ARID1A expression between non-atypical and
atypical endometriosis with CCC (p=0,001 and p=0,0015). In non-atypical
endometriosis, atypical and EAOC groups there are significant differences on the
percentage of ARID1A expression (Kruskal-Walis test p=0,011). Post Hoc
analysis were done using Mann-Whitney test and there are significant differences
on ARID1A expression between non-atypical and atypical endometriosis with
EAOC (p=0,005 and p=0,008).
Conclusion: Expression of ARID1A in non atypical and atypical endometriosis
are significantly higher compared to ovarian CCC and EAOC. So, we can say that
ARID1A may be used as a marker for malignancy transformation in
endometriosis.
;Background: Endometriosis is one of the most common gynecological
abnormalities found. Endometriosis cyst in the ovary also exhibited changes in
epithelial cyst just like endometrium in the uterus. Changes in the epithelial cells
also include metaplasia, hyperplasia, atyphia even changes toward malignan
characteristics. Nowadays, there are some research that linked endometriosis and
clear cell ovarian cancer which is known with endometriosis-associated ovarian
carcinoma (EAOC) it is reported that there?s a mutation that activated tumor
suppressor gene (ARID1A), so protein BAF250a is not expressed in Clear Cell
Carcinoma (CCC) in the ovarium.
Materials and Methods: Immunohistochemistry staining of ARID1A were done
in 20 samples of non-atypical endometriosis, 20 samples of atypical
endometriosis, 20 samples of CCC in the ovarium from the year 2012 until march
2015. From the group that experienced CCC we get 9 cases of EAOC. After that,
we see if there?s any difference in the percentage of ARID1A expression in nonatypical
endometrosis, atypical endometriosis, CCC in the ovarium and
endometriosis with CCC( EAOC).
Results: In non-atypical endometriosis, atypical and CCC cases groups there are
significant differences on the percentage of ARID1A expression (Kruskal-Walis
test p=0,0035). Post Hoc analysis were done using Mann-Whitney test and there
are significant differences on ARID1A expression between non-atypical and
atypical endometriosis with CCC (p=0,001 and p=0,0015). In non-atypical
endometriosis, atypical and EAOC groups there are significant differences on the
percentage of ARID1A expression (Kruskal-Walis test p=0,011). Post Hoc
analysis were done using Mann-Whitney test and there are significant differences
on ARID1A expression between non-atypical and atypical endometriosis with
EAOC (p=0,005 and p=0,008).
Conclusion: Expression of ARID1A in non atypical and atypical endometriosis
are significantly higher compared to ovarian CCC and EAOC. So, we can say that
ARID1A may be used as a marker for malignancy transformation in
endometriosis.
;Background: Endometriosis is one of the most common gynecological
abnormalities found. Endometriosis cyst in the ovary also exhibited changes in
epithelial cyst just like endometrium in the uterus. Changes in the epithelial cells
also include metaplasia, hyperplasia, atyphia even changes toward malignan
characteristics. Nowadays, there are some research that linked endometriosis and
clear cell ovarian cancer which is known with endometriosis-associated ovarian
carcinoma (EAOC) it is reported that there?s a mutation that activated tumor
suppressor gene (ARID1A), so protein BAF250a is not expressed in Clear Cell
Carcinoma (CCC) in the ovarium.
Materials and Methods: Immunohistochemistry staining of ARID1A were done
in 20 samples of non-atypical endometriosis, 20 samples of atypical
endometriosis, 20 samples of CCC in the ovarium from the year 2012 until march
2015. From the group that experienced CCC we get 9 cases of EAOC. After that,
we see if there?s any difference in the percentage of ARID1A expression in nonatypical
endometrosis, atypical endometriosis, CCC in the ovarium and
endometriosis with CCC( EAOC).
Results: In non-atypical endometriosis, atypical and CCC cases groups there are
significant differences on the percentage of ARID1A expression (Kruskal-Walis
test p=0,0035). Post Hoc analysis were done using Mann-Whitney test and there
are significant differences on ARID1A expression between non-atypical and
atypical endometriosis with CCC (p=0,001 and p=0,0015). In non-atypical
endometriosis, atypical and EAOC groups there are significant differences on the
percentage of ARID1A expression (Kruskal-Walis test p=0,011). Post Hoc
analysis were done using Mann-Whitney test and there are significant differences
on ARID1A expression between non-atypical and atypical endometriosis with
EAOC (p=0,005 and p=0,008).
Conclusion: Expression of ARID1A in non atypical and atypical endometriosis
are significantly higher compared to ovarian CCC and EAOC. So, we can say that
ARID1A may be used as a marker for malignancy transformation in
endometriosis.
"
Fakultas Kedokteran Universitas Indonesia, 2015
SP-PDF
UI - Tugas Akhir  Universitas Indonesia Library
cover
Rosita Alfi Syahrin
"Latar Belakang: Tipe terbanyak dari limfoma non-Hodgkin (LNH) sel B adalah Diffuse Large B-cell Lymphoma (DLBCL) yang merupakan entitas heterogen. Hans membagi DLBCL menjadi subtipe Germinal Center B-cell like (GCB) dan non-Germinal Center B-cell like (non-GCB) dengan tehnik pemeriksaan imunohistokimia menggunakan CD10, BCL6 dan MUM1. Caspase-3 adalah protein yang berperan utama dalam mekanisme apoptosis dan dapat mengalami mutasi somatik pada LNH. Imunoekspresi Caspase-3 dapat berhubungan dengan kesintasan pasien DLBCL. Tujuan penelitian ini untuk mengetahui perbedaan imunoekspresi Caspase-3 pada DLBCL subtipe GCB dan non-GCB.
Bahan dan Metode: Pemeriksaaan imunoekspresi Caspase-3 pada 41 kasus DLBCL yang terdiri atas 18 kasus subtipe GCB dan 23 kasus non-GCB dilakukan dengan tehnik imunohistokimia . Subjek penelitian berasal dari RSCM dan enam rumah sakit lainnya di Jakarta.
Hasil: Kasus DLBCL subtipe GCB memberikan hasil positif pada pulasan Caspase-3 berjumlah 13 kasus (72%) dan negatif berjumlah 5 kasus (28%). Hasil yang didapatkan dari subtipe non-GCB yaitu positif berjumlah 5 kasus (22%) dan negatif berjumlah 18 kasus (78%). Terdapat perbedaan bermakna imunoekspresi Caspase-3 antara DLBCL subtipe GCB dengan subtipe non-GCB (p = 0,002).
Kesimpulan: Imunoekspresi Caspase-3 menunjukkan positivitas yang lebih tinggi pada DLBCL subtipe GCB dibandingkan dengan subtipe non-GCB.

Background: The most common type of B-cell non-Hodgkin lymphoma (NHL) is diffuse large B-cell lymphoma (DLBCL) which is heterogeneous. Hans divided DLBCL into Germinal Center B-cell-like (GCB) and non-Germinal Center B-cell-like (non-GCB) subtypes by using immunohistochemistry staining with CD10, BCL6 and MUM1. Caspase-3 is a protein that functions as a key role in the mechanism of apoptosis and may have somatic mutation in NHL. Immunoexpression of Caspase-3 could be associated with the survival of DLBCL patient. This study was performed to analyze the difference of Caspase-3 immunoexpression between GCB and non-GCB subtypes of DLBCL.
Materials and Methods: Caspase-3 immunoexpression examination was performed in 41 DLBCL cases, consisted of 18 cases of GCB and 23 cases of non-GCB subtypes by using immunohistochemistry technique. The cases came from RSCM and 6 other hospitals in Jakarta.
Result: The number of GCB subtype which showed positive Caspase-3 staining was 13 cases (72%) and negative in 5 cases (28%). The number of non-GCB subtype which showed positive Caspase-3 staining was 5 cases (22%) and negative in 18 cases (78%). There was significant difference of Caspase-3 immunoexpression between GCB and non-GCB subtype of DLBCL (p = 0,002).
Conclusion: The positivity of Caspase-3 expression was higher in GCB subtype than non-GCB subtype.
"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2014
SP-Pdf
UI - Tugas Akhir  Universitas Indonesia Library
<<   1 2   >>